Hyophen and Tetrabenazine
Determining the interaction of Hyophen and Tetrabenazine and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using tetrabenazine together with methylene blue is not recommended. Combining these medications can cause dangerously high blood pressure and even death. You may use tetrabenazine only after you have been off methylene blue for at least 14 days. You should seek immediate medical attention if you experience sudden and severe headache, blurred vision, confusion, seizures, chest pain, nausea or vomiting, sudden numbness or weakness (especially on one side of the body), speech difficulties, fever, sweating, lightheadedness, and/or fainting during treatment with methylene blue, as these may be signs and symptoms of excessively high blood pressure. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:CONTRAINDICATED: Tetrabenazine may cause excitation and hypertension in patients treated with monoamine oxidase inhibitors (MAOIs). The proposed mechanism has not been fully established but may be related to interference with biogenic amine storage. In addition, tetrabenazine may have depressant effects and may exacerbate depression. The same interaction can be expected for deutetrabenazine, a deuterium-containing analog of tetrabenazine.
MANAGEMENT: Concurrent administration of tetrabenazine and deutetrabenazine with MAOIs or other agents that possess MAOI activity (e.g., furazolidone, linezolid, methylene blue, procarbazine) is considered contraindicated. At least 14 days should elapse between discontinuation of MAOI therapy and initiation of treatment with either tetrabenazine or deutetrabenazine, and vice versa.
- "Product Information. Austedo (deutetrabenazine)." Teva Pharmaceuticals USA, North Wales, PA.
- "Product Information. Xenazine (tetrabenazine)." Prestwick Pharmaceuticals Inc, Washington DC, VA.
- "Product Information. Nitoman (tetrabenazine)." Cambridge Laboratories Ltd, Wallsend, Tyne & Wear, .
Generic Name: benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate
Brand name: Hyophen, Prosed/DS, Urophen MB
Synonyms: Hyophen Tablets
Generic Name: tetrabenazine
Brand name: Xenazine
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyophen-Tetrabenazine Tablets
- Hyophen-Tetracaine
- Hyophen-Tetracaine (Systemic)
- Hyophen-Tetracaine injection
- Hyophen-Tetracaine topical
- Hyophen-Tetracaine Topical application
- Tetrabenazine-Hyophen Tablets
- Tetrabenazine-Hyoscine Injection
- Tetrabenazine-Hyoscyamine
- Tetrabenazine-Hyoscyamine and phenyltoloxamine
- Tetrabenazine-Hyoscyamine Extended-Release Tablets
- Tetrabenazine-Hyoscyamine Injection